11.78
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ASRT Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$11.48
Aprire:
$11.61
Volume 24 ore:
20,936
Relative Volume:
0.47
Capitalizzazione di mercato:
$75.08M
Reddito:
$169.43M
Utile/perdita netta:
$-186.01M
Rapporto P/E:
-5.8317
EPS:
-2.02
Flusso di cassa netto:
$70.07M
1 W Prestazione:
+5.84%
1M Prestazione:
+7.32%
6M Prestazione:
+8.61%
1 anno Prestazione:
-3.05%
Assertio Holdings Inc Stock (ASRT) Company Profile
Nome
Assertio Holdings Inc
Settore
Telefono
(224) 419-7106
Indirizzo
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Confronta ASRT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ASRT
Assertio Holdings Inc
|
11.70 | 73.66M | 169.43M | -186.01M | 70.07M | -2.02 |
|
ZTS
Zoetis Inc
|
123.97 | 55.12B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.97 | 50.80B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.27 | 45.60B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.64 | 36.04B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
470.64 | 20.23B | 3.08B | 1.24B | 1.07B | 25.61 |
Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-26 | Iniziato | Maxim Group | Buy |
| 2024-07-03 | Iniziato | H.C. Wainwright | Buy |
| 2022-11-07 | Iniziato | Lake Street | Buy |
| 2018-11-30 | Downgrade | Mizuho | Buy → Neutral |
Assertio Holdings Inc Borsa (ASRT) Ultime notizie
Wall Street Analysts Think Assertio (ASRT) Could Surge 249.87%: Read This Before Placing a Bet - sharewise.com
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year? - sharewise.com
Assertio regains nasdaq compliance after successful reverse split By Investing.com - Investing.com Nigeria
Short Interest in Assertio Holdings, Inc. (NASDAQ:ASRT) Decreases By 92.8% - MarketBeat
Assertio Therapeutics announces 1-for-15 reverse stock split - MSN
Assertio regains compliance with Nasdaq minimum bid price requirement By Investing.com - Investing.com Canada
Assertio regains Nasdaq compliance after bid price recovery - MSN
Assertio regains compliance with Nasdaq minimum bid price requirement - Investing.com
Assertio regains nasdaq compliance after successful reverse split - Investing.com
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements - The Joplin Globe
Los Angeles Daily NewsAssertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements - FinancialContent
How Recent Valuation Reset And Leadership Changes Are Reframing The Assertio Holdings (ASRT) Story - Yahoo Finance
Assertio Reports Positive Clinical Trial Results for Rolvedon with Same-Day Dosing - Intellectia AI
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial - joplinglobe.com
Same-day cancer drug shot shows similar results to next-day dosing in trial - Stock Titan
Why Assertio Holdings Inc. stock is trending among retail traders2025 Investor Takeaways & AI Forecast Swing Trade Picks - Улправда
Why Assertio Holdings Inc. stock remains a top recommendationForecast Cut & Real-Time Sentiment Analysis - Улправда
What momentum indicators show for Assertio Holdings Inc. stockJuly 2025 Intraday Action & Trade Opportunity Analysis Reports - Улправда
FY2025 EPS Estimates for Assertio Raised by HC Wainwright - Defense World
FY2025 EPS Estimates for Assertio Increased by HC Wainwright - MarketBeat
HC Wainwright Forecasts Assertio’s Q4 Earnings (NASDAQ:ASRT) - Defense World
What is HC Wainwright's Forecast for Assertio Q4 Earnings? - MarketBeat
Support Test: Can Assertio Holdings Inc stock deliver 10 annual returnsMarket Performance Recap & Weekly Watchlist of Top Performers - moha.gov.vn
H.C. Wainwright raises Assertio stock price target to $35 following reverse split - Investing.com Canada
H.C. Wainwright raises Assertio stock price target to $35 following reverse split By Investing.com - Investing.com South Africa
Assertio (NASDAQ:ASRT) Upgraded at Zacks Research - Defense World
Analysts’ Top Healthcare Picks: Assertio Therapeutics (ASRT), REPRO-MED Systems (KRMD) - The Globe and Mail
Assertio (NASDAQ:ASRT) Raised to Strong-Buy at Zacks Research - MarketBeat
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024 - marketscreener.com
Assertio Holdings announces 1-for-15 reverse stock split - MSN
ASSERTIO HOLDINGS INC Financial Disclosures & Filings - TradingView — Track All Markets
Assertio (NASDAQ:ASRT) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Assertio Holdings, Inc.'s (NASDAQ:ASRT) Shares Lagging The Industry But So Is The Business - simplywall.st
Assertio to implement 1-for-15 reverse stock split on Dec 26 - Investing.com Australia
Assertio Holdings, Inc. announces 1-for-15 reverse stock split - marketscreener.com
Assertio to Effect 1-for-15 Reverse Stock Split - marketscreener.com
Assertio Therapeutics Announces 1-for-15 Reverse Stock Split - TipRanks
Assertio to implement 1-for-15 reverse stock split on Dec 26 By Investing.com - Investing.com South Africa
Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split - marketscreener.com
Assertio Holdings Inc Azioni (ASRT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):